Richard A. Paulson

President and CEO, Director, Karyopharm Therapeutics Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.1M

Companies

Latest trade

May 14, 2026

Companies

Karyopharm Therapeutics Inc.President and CEO, Director −$0.1M

Trades

KPTI Sold 2,203 shares at $9.50 $0.0M May 14

KPTI Sold 12,361 shares at $9.41 $0.1M Mar 2

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.